The Protein A Resin Market is estimated to be valued at US$ 474.0 Mn in 2022 and is expected to exhibit a CAGR of 8.5% over the forecast period of 2020-2027, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Protein A resin is widely used in the biopharmaceutical industry for the purification of monoclonal antibodies. It offers several advantages such as high selectivity, high binding capacity, and low non-specific binding, making it an ideal choice for antibody purification. The increasing demand for monoclonal antibodies in various therapeutic applications is driving the growth of the Protein A resin market. Additionally, the rising prevalence of chronic diseases, such as cancer and autoimmune disorders, is further propelling the demand for Protein A resin for drug development and research purposes. Furthermore, the advancements in biotechnology and recombinant DNA technology have increased the production of monoclonal antibodies, leading to the increased adoption of Protein A resin in the biopharmaceutical industry.
B) Market Key Trends:
One key trend in the Protein A Resin market is the growing adoption of single-use Protein A resin columns. Single-use columns offer several advantages such as cost-effectiveness, reduced risk of cross-contamination, and flexibility in production scale-up/down. These columns eliminate the need for column cleaning, validation, and re-use, thereby saving time and resources. Moreover, single-use columns are more environmentally friendly as they generate less waste compared to traditional resin columns. The increasing preference for single-use technologies and the rising demand for personalized medicines are driving the adoption of single-use Protein A resin columns in the biopharmaceutical industry. This trend is expected to continue over the
Segment Analysis:
The Protein A Resin Market can be segmented based on application, end-user, and region.
In terms of application, the dominant segment in the Protein A Resin Market is the antibody purification segment. This is due to the increasing demand for monoclonal antibodies for therapeutic applications, as well as for research purposes. Monoclonal antibodies are widely used in the treatment of various diseases such as cancer, autoimmune disorders, and infectious diseases. The antibody purification segment is expected to witness significant growth during the forecast period, mainly driven by the increasing R&D activities in the field of biotechnology and the growing demand for effective therapeutics.
Key Takeaways:
The global Protein A Resin Market Size is expected to witness high growth, exhibiting a CAGR of 8.5% over the forecast period of 2020-2027. This growth can be attributed to several factors. Firstly, the increasing prevalence of chronic diseases such as cancer and autoimmune disorders is driving the demand for monoclonal antibodies, which in turn is driving the demand for Protein A resin for antibody purification. Moreover, the growing investments in R&D activities in the biotechnology sector and the increasing adoption of Protein A resin for various research applications are also contributing to the market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the Protein A Resin Market. This can be attributed to several factors such as the presence of major biopharmaceutical companies, the high adoption of advanced bioprocessing technologies, and the increasing demand for biologic therapeutics in this region. Moreover, favorable government initiatives, well-established healthcare infrastructure, and a strong presence of key market players in North America are further fueling the market growth in this region.
Key players operating in the Protein A Resin Market are GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. These players are adopting various strategies such as mergers and acquisitions, collaborations, and product launches to strengthen their market position and expand their product portfolio. The presence of these key players in the market is expected to contribute to the market growth and drive innovation in the Protein A Resin Market.
Comments
0 comment